Acorda Therapeutics, Inc. (Acorda) is a commercial-stage biopharmaceutical company engaged in the identification, development and commercialization of therapies that improve neurological function in people with multiple sclerosis (MS), spinal cord injury (SCI) and other disorders of the nervous system. The first product for which the Company completed clinical development, Ampyra (dalfampridine) Extended Release Tablets (Ampyra), was approved by the United States Food and Drug Administration (FDA) in January 2010, as a treatment to improve walking in patients with MS. Ampyra is an extended-release tablet formulation of dalfampridine (4-aminopyridine (4-AP)), which was previously referred to as fampridine. Acorda's marketed product, Zanaflex Capsules, is approved by the FDA as a short-acting drug for the management of spasticity.

Epineuron is a bioelectronic medicine company bringing a new standard of care for peripheral nerve repair and regeneration. The company is developing a suite of surgical solutions for repairing and treating peripheral nerve injuries with the mission of becoming the world leader in bioelectronic nerve care, starting with its neuroregenerative therapy.

Upsher-Smith Laboratories, Inc. manufactures generic pharmaceuticals. It serves the pharmacists, physicians, and patients. The firm offers manufacturing, distribution, sales, and marketing services. The company was founded by Frederick Alfred Upsher Smith in 1919 and is headquartered in Maple Grove, MN.

L&K BIOMED Co., Ltd. engages in the manufacture and sale of implants for vertebra. Its products include spinal fixation devices and spinal surgery products used in orthopedics and neurosurgery. The company was founded on December 22, 2008 and is headquartered in Yongin-si, South Korea.

Shenzhen Bao'an District Shajing People's Hospital is a private company headquartered in Shenzhen, China. The firm provides health care services.

Qingdao Marine Biomedical Research Institute Co., Ltd., established on 2013-07-26, Business scope includes licensed projects:Drug Wholesale;pharmaceutical production;Drug retail;Pharmaceutical commissioned production;Health food production;Health food sales;food production;food business(Selling prepackaged food);food business(sell bulk food);food business;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Sales of formula food for special medical purposes;Production of formula food for special medical purpose;Cosmetic production;Production of sterile equipment;Disinfection equipment sales;Inspection and testing service;Disinfectant production(Free of Hazardous Chemicals).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Medical Research and Experimental Development;Engineering and Technology Research and Experimental Development;New material technology research and development;New material technology promotion service;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Specialty Chemicals Sales(Free of Hazardous Chemicals);Manufacturing of daily chemical products;Sales of daily chemical products;Cosmetics Wholesale;Cosmetics Retail;Disinfectant sales(Free of Hazardous Chemicals);Extraction of marine bioactive substances,purification,Synthesis technology research and development;Research and development of bio-based materials technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Offshore engineering design and module design and manufacturing services;Asset management services for self-owned capital investment.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Meiji Co., Ltd. produces and sells milk, dairy, confectioneries, and food. Its products include cheese, ice cream, chocolate, infant formula, whey protein, beauty supplements, and yogurt. The company was founded on December 21, 1917 and is headquartered in Tokyo, Japan.

The Kyungpook National University Hospital is located in Daegu, South Korea. It was derived from the DaeGuDongIn Hospital which had opened in 1907. It has played as centered hospital of Gyeongsangbuk-do. As 1952 Kyungpook National University is established, it is following to the Kyungpook National University Hospitals. It is known to Korean as important general hospitals.

INHA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION provides practical help for improving the technology of an industrial field.

Akzo Nobel NV is a holding company, which engages in the manufacture and sale of coating and paint products. engages in the production and marketing of paints and coatings. It operates through the following segments: Decorative Paintings, Performance Paintings, and Corporate and Others. The Decorative Paints segment manufactures and supplies a range of interior and exterior decoration and protection products for professional and do-it-yourself markets. The Performance Coatings segment produces automotive and aerospace; industrial; marine and protective; and powder coatings. The company was founded in 1792 and is headquartered in Amsterdam, Netherlands.

Shaanxi Zhonghong Kerui Regenerative Medicine Research Institute Co., Ltd., established on 2019-03-28, Business scope includes stem cell storage,Research and development of stem cell products,technical consulting,Technology Transfer and Technical Services;Medical cosmetology,life beauty,cosmetic,skin care products,Product Development of Daily Cleaning Products,production and sales;Pre-packaged food,functional food,Healthy food,Formula food for special medical purpose,Disinfectant,disinfectant,Research and development of hygiene products,Sales;Health Management Consulting;medical technology development;Medical Services and Medical Examinations;Research and sales of plant and animal tissue extracts;Research and development of biological products and biotechnology,technology transfer,Technical Consulting and Technical Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Hunter-Fleming Ltd. dvelops pharmaceutical products. The company was founded by James R. Murray, John S. Fox and Ernst Wülfert in February 1999 and is headquartered in Brixham, the United Kingdom.

Hunan Maternity & Children Health Hospital (doing business as Hu'nan Maternal & Child Hygiene Hospital Medical Treatment Beauty Center) is a private company headquartered in Changsha, China. The firm provides children and maternity health care servicers.

Denka Corp., part of Denka Co., Ltd., is an American company located in New York, NY. The firm manufactures and distributes chemical products.